talinolol has been researched along with rifampin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Collett, A; Hallifax, D; Tanianis-Hughes, J; Warhurst, G | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Artursson, P; Mateus, A; Matsson, P | 1 |
| Bloomer, WD; Papadopoulou, MV; Rosenzweig, HS | 1 |
| Eslamimehr, S; Franzblau, SG; Kong, Y; Kurosu, M; Lemieux, MR; Mitachi, K; Park, F; Pressly, JD; Siricilla, S; Wang, Y; Yang, D | 1 |
| Franke, G; Fritz, P; Hachenberg, T; Kauffmann, HM; Knoke, M; Kroemer, HK; Oertel, R; Schrenk, D; Siegmund, W; Terhaag, B; von Richter, O; Warzok, R; Weinbrenner, A; Westphal, K; Zschiesche, M | 1 |
| Franke, G; Gramatté, T; Hoffmann, A; Klebingat, KJ; Kroemer, HK; Lemma, GL; Siegmund, W; Terhaag, B; Zschiesche, M | 1 |
| Chiou, WL; Jeong, HY; Ma, C; Wu, TC | 1 |
| Caliebe, A; Cascorbi, I; Haenisch, S; May, K; Siegmund, W; Wegner, D | 1 |
| Dazert, E; Lederer, K; Oswald, S; Saljé, K; Siegmund, W; Warzok, R | 1 |
| Costales, C; Eatemadpour, S; Kimoto, E; Lazzaro, S; Varma, MV; Yamazaki, S | 1 |
| D'Argenio, DZ; Siegmund, W; Weiss, M | 1 |
1 trial(s) available for talinolol and rifampin
| Article | Year |
|---|---|
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Antitubercular Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Duodenum; Endoscopy, Digestive System; Enzyme Induction; Humans; Immunohistochemistry; Infusions, Intravenous; Male; Propanolamines; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Up-Regulation | 2000 |
14 other study(ies) available for talinolol and rifampin
| Article | Year |
|---|---|
Predicting P-glycoprotein effects on oral absorption: correlation of transport in Caco-2 with drug pharmacokinetics in wild-type and mdr1a(-/-) mice in vivo.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport, Active; Caco-2 Cells; Cell Membrane Permeability; Humans; Intestinal Absorption; Mice; Mice, Knockout; Pharmacokinetics; Spectrometry, Mass, Electrospray Ionization | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Humans; Imidazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Structure-Activity Relationship; Triazoles | 2017 |
An antimycobacterial pleuromutilin analogue effective against dormant bacilli.
Topics: Administration, Oral; Animals; Antitubercular Agents; Area Under Curve; Biological Availability; Caco-2 Cells; Diterpenes; Female; Half-Life; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pleuromutilins; Polycyclic Compounds | 2018 |
Stereoselective disposition of talinolol in man.
Topics: Adrenergic beta-Antagonists; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Interactions; Enzyme Inhibitors; Humans; Male; Microsomes, Liver; Molecular Conformation; Propanolamines; Rifampin; Statistics, Nonparametric | 2002 |
Unexpected lack of effect of the rifampin-induced P-glycoprotein on the oral bioavailability of its substrate, talinolol, in humans: implication in phenotyping.
Topics: Administration, Oral; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Humans; Phenotype; Propanolamines; Rifampin; Stereoisomerism; Substrate Specificity | 2003 |
Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Biological Availability; DNA Primers; Duodenum; Female; Gene Frequency; Genotype; Humans; Infusions, Intravenous; Intestinal Mucosa; Intestines; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nucleic Acid Synthesis Inhibitors; Polymorphism, Single Nucleotide; Propanolamines; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger | 2008 |
Effects of rifampicin, dexamethasone, St. John's Wort and Thyroxine on maternal and foetal expression of Abcb1 and organ distribution of talinolol in pregnant rats.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Brain; Dexamethasone; Female; Fetus; Hypericum; Liver; Placenta; Pregnancy; Propanolamines; Rats; Rats, Wistar; Rifampin; RNA, Messenger; Thyroxine | 2012 |
Physiologically-Based Pharmacokinetic Modeling Approach to Predict Rifampin-Mediated Intestinal P-Glycoprotein Induction.
Topics: Administration, Oral; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dabigatran; Digoxin; Drug Interactions; Female; Gene Expression Regulation; Healthy Volunteers; Humans; Intestinal Mucosa; Male; Models, Biological; Propanolamines; Quinidine; Rifampin | 2019 |
Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin.
Topics: Adrenergic beta-Antagonists; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Humans; Propanolamines; Rifampin | 2022 |